The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2293-2301

  Amano, Hirofumi ^a   Amano, Eri ^a   Moll, Thomas ^a   Marinkovic, Dragan ^b   Ibnou Zekri, Nabila ^a   Martinez Soría, Eduardo ^a   Semac, Isabelle ^a   Wirth, Thomas ^b   Nitschke, Lars ^c   Izui, Shozo ^a,d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d CMU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M; INTEGRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENE; YAA GENE;

EID: 0037371122     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2293     Document Type: Article

References (55)

1. Murphy, E. D., and J. B. Roths. 1979. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22:1188.
2. Izui, S., M. Iwamoto, L. Fossati, R. Merino, S. Takahashi, and N. Ibnou-Zekri. 1995. The Yaa gene model of systemic lupus erythematosus. Immunol. Rev. 144:137.
3. Hudgins, C. C., R. T. Steinberg, D. M. Klinman, M. J. P. Reeves, and A. D. Steinberg. 1985. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134:3849.
4. 1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18:911.
5. - bone marrow chimeric mice. J. Exp. Med. 174:1023.
6. + B cells to produce lupus autoantibodies in vivo. Eur. J. Immunol. 25:3412.
7. Izui, S., R. Merino, L. Fossati, and M. Iwamoto. 1994. The role of the Yaa gene in lupus syndrome. Int. Rev. Immunol. 11:211.
8. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
9. 2-microglobulin-dependent and independent forms. J. Immunol. 161:1710.
10. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:7198.
11. Won, W.-J., and J. F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:5605.
12. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617.
13. Tanigaki, K., H. Han, N. Yamamoto. K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immun. 3:443.
14. Zeng, D., M. K. Lee, J. Tung, A. Bredolan, and S. Strober. 2000. A role of CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164:5000.
15. 1 mice. Clin. Immunol. 94:51.
16. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocyte disorders along with autoimmune manifestations. J. Exp. Med. 190:1697.
17. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schnieder, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453.
18. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886.
19. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195:181.
20. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immun. 1:31.
21. Girkontaite, I., K. Missy, V. Sakk, A. Harenberg, K. Tedford, T. Pötzel, K. Pfeffer, and K.-D. Fischer. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immun. 2:855.
22. Fukui, Y., O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi, M. Noda, M. Oike, T. Shirai, and T. Sasazuki. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 412:826.
23. Martin, F., and J. F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12:39.
24. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603.
25. Seo, S.-J., J. Buckler, and J. Erikson. 2001. Novel roles of Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice. J. Immunol. 166:3710.
26. Samardzic, T., D. Marinkovic, C.-P. Danzer, J. Gerlach, L. Nitschke, and T. Wirth. 2002. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 32:561.
27. Lam, K.-P., and K. Rajewsky. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190:471.
28. Watanabe, N., S. Nisitani, K. Ikuta, M. Suzuki, T. Chiba, and T. Honjo. 1999. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190:461.
29. Merino, R., M. Iwamoto, L. Fossati, P. Muniesa, K. Araki, S. Takahashi, J. Huarte, K.-I. Yamamura, J.-D. Vassalli, and S. Izui. 1993. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E α chain. J. Exp. Med. 178:1189.
30. Merino, R., L. Fossati, M. Lacour, R. Lemoine, M. Higaki, and S. Izui. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22:295.
31. Fossati, L., M. Iwamoto, R. Merino, and S. Izui. 1995. Selective accelerating effect of the Yaa gene on immune responses against self and foreign antigens. Eur. J. Immunol. 25:166.
32. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol. 7:133.
33. Andersson, J., F. Melchers, and A. Rolink. 1995. Stimulation by T cell independent antigens can relieve the arrest of differentiation of immature auto-reactive B cells in the bone marrow. Scand. J. Immunol. 42:21.
34. Starobinski, M., M. Lacour, L. Reininger, and S. Izui. 1989. Autoantibody repertoire analysis in normal and lupus-prone mice. J. Autoimmun. 2:657.
35. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260.
36. Yan, M. H., S. A. Marsters, I. S. Grewal, H. Wang, A. Ashkenazi, and V. M. Dixit. 2000. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat. Immun. 1:37.
37. Lu, T. T., and J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297:409.
38. Boyd, A. W., K. C. Anderson, A. S. Freedman, D. C. Fischer, B. Slaughenhaupt, S. F. Schlossman, and L. M. Nadler. 1985. Studies of in vitro activation and differentiation of human lymphocytes: phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J. Immunol. 134:1516.
39. Takahashi, K., Y. Kozono, T. J. Waldschmidt, D. Berthiaume, R. J. Quigg, A. Baron, and V. M. Holers. 1997. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MLR/lpr mice. J. Immunol. 159:1557.
40. Chen, X., F. Martin, K. A. Forbush, R. M. Perlmutter, and J. F. Kearney. 1997. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9:27.
41. Wither, J. E., A. D. Paterson, and B. Vukusic. 2000. Genetic dissection of B cell traits in New Zealand black mice: the expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2. Eur. J. Immunol. 30:356.
42. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435.
43. Gray, D., D. S. Kumararatne, J. Lortan, M. Khan, and I. C. M. Maclennan. 1984. Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology 52:659.
44. Prodeus, A. P., S. Georg, L. M. Shen, O. O. Pozdnyakova, L. Chu, E. M. Alicot, C. C. Goodnow, and M. C. Carroll. 1998. A critical role for complement in maintenance of self-tolerance. Immunity, 9:721.
45. Ehrenstein, M. R., H. T. Cook, and M. S. Neuberger. 2000. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J. Exp. Med. 191:1253.
46. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97:1184.
47. O'Keefe, T. L., G. T. Williams, F. D. Batista, and M. S. Neuberger. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189:1307.
48. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301.
49. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549.
50. high B cells: a population of mixed origin. Eur. J. Immunol. 29:3285.
51. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/21 complex. Annu. Rev. Immunol. 18:393.
52. Izui, S., P. J. McConahey, and F. J. Dixon. 1978. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol. 121:2213.
53. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352.
54. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798.
55. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371.